CytoMed Therapeutics Limited (GDTC) Put/Call Volume History

Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.

CytoMed Therapeutics Limited (GDTC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $12.1M, listed on NASDAQ, employing roughly 42 people, carrying a beta of 0.02 to the broader market. CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. Led by Chee Kong Choo, public since 2023-04-14.

Put/call volume history tracks trading activity and sentiment over time. No recent options activity for GDTC as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options volume is reported and how to read the data →